146 related articles for article (PubMed ID: 12519589)
21. Modafinil for excessive daytime sleepiness in myotonic dystrophy type 1--the patients' perspective.
Hilton-Jones D; Bowler M; Lochmueller H; Longman C; Petty R; Roberts M; Rogers M; Turner C; Wilcox D
Neuromuscul Disord; 2012 Jul; 22(7):597-603. PubMed ID: 22425060
[TBL] [Abstract][Full Text] [Related]
22. Quality of life and excessive daytime sleepiness in children and adolescents with myotonic dystrophy type 1.
Ho G; Widger J; Cardamone M; Farrar MA
Sleep Med; 2017 Apr; 32():92-96. PubMed ID: 28366348
[TBL] [Abstract][Full Text] [Related]
23. Loss of serotonin-containing neurons in the raphe of patients with myotonic dystrophy: a quantitative immunohistochemical study and relation to hypersomnia.
Ono S; Takahashi K; Jinnai K; Kanda F; Fukuoka Y; Kurisaki H; Mitake S; Inagaki T; Yamano T; Nagao K
Neurology; 1998 Feb; 50(2):535-8. PubMed ID: 9484393
[TBL] [Abstract][Full Text] [Related]
24. Hypersomnia associated with alveolar hypoventilation in myotonic dystrophy.
Hansotia P; Frens D
Neurology; 1981 Oct; 31(10):1336-7. PubMed ID: 7202141
[No Abstract] [Full Text] [Related]
25. Treatment for Lambert-Eaton myasthenic syndrome.
Maddison P; Newsom-Davis J
Cochrane Database Syst Rev; 2003; (2):CD003279. PubMed ID: 12804456
[TBL] [Abstract][Full Text] [Related]
26. Daytime sleepiness and myotonic dystrophy.
Laberge L; Gagnon C; Dauvilliers Y
Curr Neurol Neurosci Rep; 2013 Apr; 13(4):340. PubMed ID: 23430686
[TBL] [Abstract][Full Text] [Related]
27. Plasma exchange for Guillain-Barré syndrome.
Raphaël JC; Chevret S; Hughes RA; Annane D
Cochrane Database Syst Rev; 2001; (2):CD001798. PubMed ID: 11406009
[TBL] [Abstract][Full Text] [Related]
28. Interventions for oropharyngeal dysphagia in children with neurological impairment.
Morgan AT; Dodrill P; Ward EC
Cochrane Database Syst Rev; 2012 Oct; 10():CD009456. PubMed ID: 23076958
[TBL] [Abstract][Full Text] [Related]
29. Sleep disorders in myotonic dystrophy type 2: a controlled polysomnographic study and self-reported questionnaires.
Romigi A; Albanese M; Placidi F; Izzi F; Liguori C; Marciani MG; Mercuri NB; Terracciano C; Vitrani G; Petrucci A; Di Gioia B; Massa R
Eur J Neurol; 2014 Jun; 21(6):929-34. PubMed ID: 23837695
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2004; (2):CD003725. PubMed ID: 15106215
[TBL] [Abstract][Full Text] [Related]
31. Comparative Sleep Disturbances in Myotonic Dystrophy Types 1 and 2.
Romigi A; Franco V; Placidi F; Liguori C; Rastelli E; Vitrani G; Centonze D; Massa R
Curr Neurol Neurosci Rep; 2018 Oct; 18(12):102. PubMed ID: 30382420
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid corticosteroids for Duchenne muscular dystrophy.
Manzur AY; Kuntzer T; Pike M; Swan A
Cochrane Database Syst Rev; 2008 Jan; (1):CD003725. PubMed ID: 18254031
[TBL] [Abstract][Full Text] [Related]
33. Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy.
Thorpy M
Curr Neurol Neurosci Rep; 2003 Mar; 3(2):165-6. PubMed ID: 12583846
[No Abstract] [Full Text] [Related]
34. Methylphenidate hydrochloride for excessive daytime sleepiness in a patient with myotonic dystrophy.
Miyamoto T; Miyamoto M; Suga T; Aizawa C; Takekawa H; Hirata K
Psychiatry Clin Neurosci; 2002 Jun; 56(3):271-2. PubMed ID: 12047591
[TBL] [Abstract][Full Text] [Related]
35. Treatment of hypersomnolence in myotonic dystrophy with a CNS stimulant.
van der Meché FG; Boogaard JM; van den Berg B
Muscle Nerve; 1986 May; 9(4):341-4. PubMed ID: 3713739
[TBL] [Abstract][Full Text] [Related]
36. Sleep apnea precipitated by pharyngeal surgery in a patient with myotonic dystrophy.
Cadieux RJ; Kales A; McGlynn TJ; Jackson D; Manders EK; Simmonds MA
Arch Otolaryngol; 1984 Sep; 110(9):611-3. PubMed ID: 6477282
[TBL] [Abstract][Full Text] [Related]
37. Monoamine oxidase B inhibitors versus other dopaminergic agents in early Parkinson's disease.
Caslake R; Macleod A; Ives N; Stowe R; Counsell C
Cochrane Database Syst Rev; 2009 Oct; (4):CD006661. PubMed ID: 19821381
[TBL] [Abstract][Full Text] [Related]
38. Predicting daytime sleepiness and fatigue: a 9-year prospective study in myotonic dystrophy type 1.
Laberge L; Gallais B; Auclair J; Dauvilliers Y; Mathieu J; Gagnon C
J Neurol; 2020 Feb; 267(2):461-468. PubMed ID: 31673761
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
McCleery J; Cohen DA; Sharpley AL
Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
[TBL] [Abstract][Full Text] [Related]
40. Fatigue in myotonic dystrophy type 1: a seven-year prospective study.
Peric S; Bjelica B; Bozovic I; Pesovic J; Paunic T; Banovic M; Brkusanin M; Aleksic K; Basta I; Pavicevic DS; Stojanovic VR
Acta Myol; 2019 Dec; 38(4):239-244. PubMed ID: 31970322
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
